Quest for the right Drug
ארסניק טריאוקסיד אס. קיי.1 מ"ג/מ"ל ARSENIC TRIOXIDE S.K.1 MG/ML (ARSENIC TRIOXIDE)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
תוך-ורידי : I.V
צורת מינון:
תרכיז להכנת תמיסה לאינפוזיה : CONCENTRATE FOR SOLUTION FOR INFUSION
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Pharmaceutical particulars : מידע רוקחי
6. PHARMACEUTICAL PARTICULARS 6.1 List of excipients Sodium hydroxide Hydrochloric acid (for pH adjustment) Water for injections 6.2 Incompatibilities In the absence of incompatibility studies, this medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6. 6.3 Shelf life Unopened vial 3 years After first opening The product should be used immediately. The expiry date of the product is indicated on the packaging materials. After dilution Chemical and physical in use stability has been demonstrated for 24 hours at 15-25°C and 48 hours at 2-8 °C. From a microbiological point of view, the product should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2-8 °C, unless dilution has taken place in controlled and validated aseptic conditions. ARSENIC TRIOXIDE S.K. 1MG/ML vial is single-dose and does not contain any preservatives. 6.4 Special precautions for storage Do not store above 300C. Do not freeze. For storage conditions after dilution of the medicinal products, see section 6.3. 6.5 Nature and contents of container ARSENIC TRIOXIDE S.K. 1MG/ML concentrate for solution for infusion. 10 ml concentrate in a clear, Type I glass vial with a bromobutyl rubber stopper grey (FluroTec coated) and sealed with an aluminium flip-off cap with polypropylene disk. Each pack contains 10 vials. 6.6 Special precautions for disposal and other handling Preparation of ARSENIC TRIOXIDE S.K. 1MG/ML Aseptic technique must be strictly observed throughout handling of ARSENIC TRIOXIDE S.K. 1MG/ML since no preservative is present. ARSENIC TRIOXIDE S.K. 1MG/ML must be diluted with 100 to 250 ml of glucose 50 mg/ml (5%) solution for injection or sodium chloride 9 mg/ml (0.9 %) solution for injection immediately after withdrawal from the vial. ARSENIC TRIOXIDE S.K. 1MG/ML must not be mixed with or concomitantly administered in the same intravenous line with other medicinal products. The diluted solution must be clear and colourless. All parenteral solutions must be inspected visually for particulate matter and discoloration prior to administration. Do not use the preparation if foreign particulate matter is present. Procedure for proper disposal ARSENIC TRIOXIDE S.K. 1MG/ML is for single use only and any unused portions of each vial must be discarded properly. Do not save any unused portions for later administration. Any unused medicinal product, any items that come into contact with the product or waste material must be disposed of in accordance with local requirements. 7. LICENCE HOLDER AND MANUFACTURER Licence holder: K.S.Kim International (SK-PHARMA) Ltd 94 YIGAL ALON STR., TEL-AVIV-YAFO, 6789139 Israel Manufacturer: Haupt Pharma Wolfratshausen GmbH Pfaffenrieder Strasse 5, 82515 Wolfratshausen, Germany
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
לא צוין
הגבלות
לא צוין
רישום
167 36 36741 99
מחיר
0 ₪
מידע נוסף
עלון מידע לרופא
19.09.21 - עלון לרופאעלון מידע לצרכן
לתרופה במאגר משרד הבריאות
ארסניק טריאוקסיד אס. קיי.1 מ"ג/מ"ל